The Stelo is available to anyone who wants to monitor their blood glucose, no prescription needed. But as an active adult without diabetes, are these extra data points worth $99 per month?

Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast - 2034” report provides the current ...

Executives from Tandem Diabetes Care (NASDAQ:TNDM) outlined how a shift toward the pharmacy channel, an expanding product portfolio, and international buildout are expected to reshape the company’s re ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. It’s been a busy week for Eufy as the Anker Innovations smart home brand has taken the ...

Our editors tested two popular glucose monitors to determine which is the best for improving ​​diet, sleep and exercise habits.

Unexplained hyperglycemic events may be due to undetected occlusions, a common problem that experts say needs to be addressed through education and technology.

New data shows positive real-world impact of the world’s first and only one-year CGM, with a full year of strong patient adherence, glucometrics and hypoglycemic outcomes Eversense 365 delivered ...

Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology at ATTD 2026.

Credential candidates in the student teaching pathway complete coursework and supervised field experiences in public schools in the final year of the MATTC program. Candidates are placed in a ...

Humana provides three types of Medicare coverage options for Medicare users. Its Medigap plans are designed to help seniors afford the cost of healthcare by covering items not traditionally included ...

Senseonics (Nasdaq:SENS) announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.